Investor Overview

Company Profile

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."

-

Nasdaq Stock Snapshot

DMAC Symbol
Nasdaq Market
-- Volume
-- Price
-- Change
Go to Detailed Stock Information ›

Upcoming Events

Release of Full Year 2018 Results and Conference Call

Conference Call details:

Date: March 20, 2019
Time: 8:00 AM CT
Web access: https://edge.media-server.com/m6/p/idbwv4bq
Dial In: (866) 962-3583 (domestic)
  (630) 652-5857 (international)
Conference ID: 6773627

Conference Call

View IR Calendar ›